News List

AbbVie's oral JAK inhibitor Rinvoq (upatinib) approved by NMPA

AbbVie recently announced that China’s National Medical Products Administration (NMPA) has approved

Genentech’s Evrysdi (risdiplam) Granted FDA Priority Review for Treatment of Pre-Symptomatic Babies Under 2 Months of Age With Spinal Muscular Atrophy (SMA)

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (

Novartis' asciminib bests Pfizer's Bosulif in phase 3 leukemia trial

Novartis’ asciminib hasoutperformedPfizer’s Bosulif in a phase 3 chronic myeloid leukemia (CML) stud

Hengrui announces new drug SHR7280

On October 11, 2021, Jiangsu Hengrui Pharmaceuticals Co., Ltd. announced that SHR0302, for the treat

Novartis secures new approval in China for Cosentyx® (secukinumab) in pediatric psoriasis

August 17, 2021 – Novartis today announced that the China National Medical Products Administration (

Bayer’s new symptomatic chronic heart failure treatment Verquvo™ (vericiguat) approved in EU

Berlin, Germany, July 21, 2021– The European Commission has granted marketing authorization in the E

USFDA approves KIT inhibitor Ayvakit (Avatinib)

CStone's partner Blueprint Medicines recently announced that the U.S. Food and Drug Administrati